From TRUTH ON THE MARKET here's an interesting question about insider trading laws:
In yesterday’s New York Times Magazine, an anonymous reader posed the following question to The Ethicist:
I am a subspecialty physician without primary responsibility for patients. I consulted on the care of the C.E.O. of a major company, the seriousness of whose illness was not being fully disclosed to shareholders. I own stock in this company. Once I complete my consultation, may I ethically sell my shares, motivated by the information I gained as a doctor?
The Ethicist responded that “[m]edical ethics do not forbid this trade, but investor ethics — a curious phrase, given recent headlines — do, so you may not make this sale.” The Ethicist went on to explain that the trade would likely be deemed illegal insider trading under the misappropriation theory.
This response — medical ethics present no bar to this trade, but the misappropriation theory does — cannot be right. Here’s why:...
Read the whole thing for their explanation.
The real question, of course, is, "What company's CEO is having serious health problems!?!?" (just kidding).
Believe he cannot trade on this information and has an obligation to suggest the CEO disclose this info in order to make it public.
Posted by: Earvin Johnson | January 24, 2006 at 09:41 AM
Check this insider trading site
Posted by: Frank | January 28, 2006 at 07:12 PM